Showing 1 - 8 results of 8 for search 'Rebecca Bolce', query time: 0.03s Refine Results
  1. 1
    Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006–2016

    Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006–2016 by Jessica Walsh, Theresa Hunter, Krista Schroeder, David Sandoval, Rebecca Bolce

    Published 2019-09-01
    Get full text
    Article
  2. 2
    The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2

    The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2 by Atul Deodhar, Dafna Gladman, Rebecca Bolce, David Sandoval, So Young Park, Soyi Liu Leage, Peter Nash, Denis Poddubnyy

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST

    Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST by Maxime Dougados, Atul Deodhar, Jürgen Braun, Uta Kiltz, Chen-Yen Lin, Tetsuya Tomita, Rebecca Bolce, Jessica Walsh, David Sandoval

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results

    Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results by Atul A. Deodhar, Philip J. Mease, Proton Rahman, Victoria Navarro-Compán, Vibeke Strand, Theresa Hunter, Rebecca Bolce, Luis Leon, Steve Lauzon, Helena Marzo-Ortega

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis

    Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis by Sofia Ramiro, James Cheng-Chung Wei, Michael J Nissen, Louis Bessette, Soyi Liu-Leage, Cédric Lukas, Rebecca Bolce, Pendleton Wickersham, Tommaso Panni, Boris Janos

    Published 2024-07-01
    Get full text
    Article
  6. 6
    Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis

    Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis by Josef S Smolen, Laura C Coates, Eric Lespessailles, Mitsumasa Kishimoto, Rebecca Bolce, Andrew J Bradley, M. Elaine Husni, Joseph F. Merola, Lisa Macpherson, Philip S. Helliwell

    Published 2022-11-01
    Get full text
    Article
  7. 7
    A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

    A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis by Bruce W. Kirkham, Alexander Egeberg, Frank Behrens, Andreas Pinter, Joseph F. Merola, Thorsten Holzkämper, Gaia Gallo, Khai Jing Ng, Rebecca Bolce, Christopher Schuster, Peter Nash, Luis Puig

    Published 2023-07-01
    Get full text
    Article
  8. 8
    Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis

    Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis by Philip Mease, Jessica A. Walsh, Xenofon Baraliakos, Robert Inman, Kurt de Vlam, James Cheng-Chung Wei, Theresa Hunter, Gaia Gallo, David Sandoval, Fangyi Zhao, Yan Dong, Rebecca Bolce, Helena Marzo-Ortega

    Published 2019-06-01
    Get full text
    Article

Search Tools: